Chemotherapy News and Research

Latest Chemotherapy News and Research

Sorafenib extends life of advanced liver cancer patients

Researchers at Mount Sinai School of Medicine in New York have found that sorafenib (Nexavar) helps patients with advanced liver cancer live about 44 percent longer compared with patients who did not receive the anti-cancer drug.

23 Jul 2008

Visualisation software to aid prostate cancer detection

Visualisation specialists See3D, a spin off company of the University of Aberystwyth, is developing unique, sophisticated computer-generated models that will help doctors to improve the diagnosis and treatment of prostate cancer.

22 Jul 2008

Abiraterone new drug for aggressive prostate cancer the best thing in 70 years

Scientists say a new drug which treats aggressive prostate cancer is possibly the most significant development in the field for 70 years.

22 Jul 2008

Suspect protein HMGB1 found to promote DNA repair, prevent cancer

An abundant chromosomal protein that binds to damaged DNA prevents cancer development by enhancing DNA repair, researchers at The University of Texas M. D. Anderson Cancer Center report online this week in the Proceedings of the National Academies of Science.

21 Jul 2008

First human tests of an injectable vaccine grown in genetically engineered plants

Plants could act as safe, speedy factories for growing antibodies for personalized treatments against a common form of cancer, according to new findings from the Stanford University School of Medicine. The findings came in the first human tests of an injectable vaccine grown in genetically engineered plants.

21 Jul 2008

Gene expression test could help determine who needs more aggressive treatment

Researchers from four leading cancer centers have confirmed that an analysis involving a panel of genes can be used to predict which lung cancer patients will have the worst survival. The finding could one day lead to a test that would help determine who needs more aggressive treatment.

21 Jul 2008

Reduced dose anthracycline post-breast cancer surgery has no effect on outcome

Canadian researchers have discovered that there is a low risk of adverse effect from reducing post-op chemo by up to 25%, according to findings published in the online journal ecancermedicalscience.

20 Jul 2008

New discovery on Candida infections

Scientists here have found that certain substances from bacteria living in the human intestine cause the normally harmless Candida albicans fungus to become highly infectious.

17 Jul 2008

New ways of exploiting medicinal uses of cannabis

Research exploring new ways of exploiting the full medicinal uses of cannabis while avoiding unwanted side-effects will be presented to pharmacologists Tuesday, 15 July by leading scientists attending the Federation of European Pharmacological Societies Congress, EPHAR 2008.

From The University of Manchester 15 Jul 2008

Quick formula could forecast which cancers chemo could kill

Researchers at the University of Rochester Medical Center have coined a simple formula that predicts how well a certain chemotherapy will work for targeting brain and other nervous system cancers. The formula, which publishes mid-July in Cancer Chemotherapy and Pharmacology, is pegged to two important proteins that compose such hard-to-kill tumors - one of which, ironically, makes them so drug-resistant in the first place.

15 Jul 2008

Chemo pill shows promise for advanced lymphoma

A new chemotherapy pill for people with stubborn lymphomas is showing promise in early clinical studies, according to scientists at the University of Rochester's James P. Wilmot Cancer Center. Doctors reported that the drug is halting disease in nearly half of the patients with two forms of lymphoma participating in early clinical trials in Rochester and across the country.

15 Jul 2008

Researchers step closer to delivering cancer-killing drugs to pediatric brain tumors

An interdisciplinary team of researchers at Washington University in St. Louis, led by Karen L. Wooley, Ph.D., James S. McDonnell Distinguished University Professor in Arts & Sciences, is a step closer to delivering cancer-killing drugs to pediatric brain tumors, similar to the tumor that Senator Ted Kennedy is suffering from.

14 Jul 2008

Scientists map anatomy of a membrane protein

In an Australian first, scientists at Sydney's Centenary Institute have mapped the anatomy of a membrane protein. This exciting discovery has the potential to turn the way we discover new drugs on its head and reduce the development time for new treatments.

14 Jul 2008

Compound honokiol, from Magnolias blocks, elusive pathway for cancer growth

A natural compound from magnolia cones blocks a pathway for cancer growth that was previously considered "undruggable," researchers have found.

13 Jul 2008

Potential new way to prevent graft-versus-host disease

A new University of Michigan study in mice suggests that a drug recently approved to fight cancer tumors is also able to reduce the effects of graft-versus-host disease, a common and sometimes fatal complication for people who have had bone marrow transplants.

10 Jul 2008

UGA discovery could lead to new ways to attack cancers by blocking their ability to grow

Human cancer cells divide and conquer. Unless physicians can control that division with surgery, chemotherapy or radiation, the wildly dividing cells will eventually destroy a person's life.

10 Jul 2008

Nanomaterials key to new strategies for blocking metastasis

A new treatment strategy using targeted nanoparticles to block metastasis with anti-cancer drugs leads to good results using significantly lower doses of toxic chemotherapy, with less collateral damage to surrounding tissue, according to a collaborative team of researchers at the Center of Nanotechnology for Treatment, Understanding, and Monitoring of Cancer at the University of California, San Diego. In designing this system, the investigators, led by David Cheresh, Ph.D., have identified what may become a generic method for using nanotechnology to target metastasis.

9 Jul 2008

Circulating tumor cells can reveal genetic signature of dangerous lung cancers

Using a miniature laboratory-on-a-chip device, a team of investigators at the Massachusetts General Hospital, led by Daniel Haber, M.D., Ph.D., and Mehmet Toner, Ph.D., both members of the MIT-Harvard Center for Cancer Nanotechnology Excellence (CCNE), has developed a method that detects and analyzes the genetic signature of rare tumor cells in the bloodstream.

9 Jul 2008

Smart nanoparticle bomb precisely targets a tumour's blood vessels

A team of researchers in the U.S. have developed a nanoparticle with the ability to precisely deliver cancer-fighting drugs.

9 Jul 2008

Natural substance Argyrin shows promise for new cancer therapies

The effective treatment of many forms of cancer continues to pose a major problem for medicine. Many tumours fail to respond to standard forms of chemotherapy or become resistant to the medication.

8 Jul 2008